WASHINGTON, D.C. - The Biotechnology Industry Organization (BIO) announced today its selection of Representative Ron Kind (D - WI) as Legislator of the Year for 2008-2009. “Congressman Kind has distinguished himself as a strong leader for policy that will help our nation's biotechnology sector thrive and...
Five regional businesses awarded funds to attend the world’s largest biotechnology convention Madison Region - Thrive, the economic development enterprise for the eight-county Madison Region, has designated five Madison Region companies for awards in its pilot BIO Partnering Grant program. Grants totaling $9,000 will enable...
Don Margolis, founder of the world's first stem cell treatment company and chairman of the Repair Stem Cell Institute, today issued a statement which took strong exception to Washington's emphasis on embryonic stem cells over both Repair (Adult) Stem Cells and induced Pluripotent stem cells...
MADISON — Thrive is releasing the first of its annual Sector Snapshots, a review of the strengths of each of Thrive’s target sectors (agriculture, biotechnology and healthcare) in the Madison Region. These sector snapshots draw a picture of the strengths and opportunities of each sector...
MADISON – www.flugen.com About Ratio Inc. Ratio Inc. is a medical device company developing technologies for pain-free delivery of large molecule drugs and other biologics into the skin. Ratio’s drug delivery system pairs an inexpensive, non-electronic pump with a microneedle array, creating a small “patch” that...
It was not until 2001 until two organizations would merge to become the new iBIO and incorporate a statewide approach. This new entity is now in its eighth year and celebrated its eighth birthday party last week during the annual iBIO IndEx conference at the...
Times are tough in the biotechnology sector. So tough that some companies are looking for ways out. The problem is, the most feasible way to do so is to find a buyer, and few companies large enough to make acquisitions are willing to shell out that...
On March 9, President Obama revoked the limits on funding research with embryonic stem cells, telling a White House audience that U.S. scientists can now apply for funding to investigate many types of embryonic stem (ES) cells, not just the few varieties permitted under the...
Two Madison-based biotech executives who steered the successful sale of Third Wave Technologies Inc. will run a publicly traded Massachusetts company that operates a similar business. Kevin T. Conroy will be president and chief executive and Maneesh K. Arora will be senior vice president and chief...
Columnist Steven Clark writes about the need for a continuing resolution to extend the life of the SBIR/STTR program, how Senator Russ Feingold may expand the SBIR program by introducing the “Strengthening Our Economy Through Small Business Innovation Act of 2009” and finally one possible...